Povero, Massimiliano, et al. “Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 22, no. 1, June 2021, doi:10.7175/fe.v22i1.1499.